[ad#PhycoBiosciences AIM Interview]

Hot Products

GeneArt® Precision TALs

March 21, 2012
AlgaeIndustryMagazine.com

TALE proteins offer precise gene editing capabilities.

TALE proteins offer precise gene editing capabilities.

Life Technologies has announced the launch of GeneArt® Precision TALs, generally referred to as TAL effector proteins (TALE), which will allow researchers in healthcare, agriculture and energy the ability to edit genomes and control gene activity with unprecedented precision and reliability.

Specific applications range from design of disease and drug efficacy models for the pharmaceutical industry to human gene therapy, a field that has been plagued by safety concerns due to random insertion of introduced genes and vectors into the genome.

TAL effectors can be designed to bind to specific DNA sequences selected by researchers and can deliver a variety of functional elements to activate or repress gene expression or to cut and insert DNA with precision. TAL proteins have an advantage over competing zinc finger technology in that they are simpler to design and bind with greater specificity, displaying fewer “off-target” events.

TAL effectors were originally discovered in bacteria that infect plants, where they target specific DNA sequences in the plant genome, rewiring gene expression to establish and propagate infection. The simple TAL effector translation code allows researchers to specifically design TAL binding proteins to bind to a DNA sequence of choice.

“Researchers give us the sequence they want to target, and we send them a gene encoding the TAL protein that will target it,” said Nathan Wood, vice president of synthetic biology at Life Technologies.

GeneArt® Precision TALs are supplied as Gateway® compatible entry clones encoding a DNA binding protein for a specific customer-submitted sequence fused to a range of customer selected effector domains. Custom TALs will typically be delivered in 3 weeks after orders are placed.

The current offering includes TALs fused with gene activators, endonucleases or a vector with multiple cloning sites providing customers the ability to link their own functional domain proteins to the TAL protein, constituting a system that is easily customized to each researcher’s needs. A TAL offering with a gene repression domain will be released at a future date.

All products referenced are for research use only, and not intended for diagnostic uses. For more information, please visit www.lifetechnologies.com/TAL

Go to Page

Copyright ©2010-2012 AlgaeIndustryMagazine.com. All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

Visit the A.I.M. Archives

AIM interview ArchivesAlgae 101 ArchivesHot Products ArchivesInnovations ArchivesMoney ArchivesProcess ArchivesResearch ArchivesScale Up ArchivesThe Buzz Archives

FREE Algae News & Updates

Sign up to receive breaking A.I.M. updates! 

From The A.I.M. Archives

— Refresh Page for More Choices
U.S. farmers and biofuels makers are watching for the Environmental Protection Agency’s (EPA’s) final decision on the 2014 Renewable Fuel Standard rules, which will set t...
Montague, Prince Edward Island-based Solarvest has announced that it has used its algal-based production platform to express bioactive therapeutic proteins. The proof of ...
In one of the first studies to examine the potential for using municipal wastewater as a feedstock for algae-based biofuels, Rice University scientists found they could e...
The Biotechnology Industry Organization (BIO) has named Solazyme CEO and co-founder Jonathan S. Wolfson as the recipient of its 2015 George Washington Carver Award for in...
Nitrogen and phosphate nutrients are among the biggest costs in cultivating algae for biofuels. Sandia National Laboratories molecular biologists Todd Lane and Ryan Davis...
With large-scale production at low cost a future possibility, many corporations in Japan are beginning to jump on the algae fuel bandwagon. Heavy industry giant IHI Corp....
Researchers at Michigan State University have built a molecular super protein tool that streamlines the molecular machinery of cyanobacteria making, they say, biofuels an...
Modesto, California-based G3 Enterprises, Inc. has entered into an agreement with Commercial Algae Professionals (CAP) to represent their unique drying technology in the ...
Algatechnologies Ltd. has launched its AstaPure® 5% Natural Astaxanthin oleoresin, derived from Haematococcus pluvialis microalgae. This latest addition to the AstaPure f...
Algae.Tec has announced that it has completed the commissioning and initial startup of an algae production plant to produce algae-based nutraceutical products. The plant ...
Kailua Kona-based Cyanotech Corporation announced financial results for the third quarter and first nine months of fiscal year 2016, ended December 31, 2015. For the thir...
An enzyme responsible for making hydrocarbons has been discovered by Texas A&M AgriLife Research scientists studying the common green microalga Botryococcus braunii. ...